A simple method for the rapid generation of recombinant adenovirus vectors

Gene Therapy

Volumn 7, Issue 12, 2000, Pages 1034-1038

  Anderson, R D ^a   Haskell, R E ^a   Xia, H ^a   Roessler, B J ^b   Davidson, B L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Gene transfer; Virus production

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTAMINATION; GENE MUTATION; GENE NUMBER; GENE THERAPY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHUTTLE VECTOR; TRANSGENE; VIRUS CULTURE; VIRUS RECOMBINANT;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0034123892     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301197     Document Type: Article

References (26)

1. Shenk T. Group C adenoviruses as vectors for gene therapy. In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press: San Diego, 1995, pp 43-54.
2. Davidson BL, Roessler BJ. Adenoviral-mediated gene transfer: potential therapeutic applications. In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press: San Diego, 1995, pp 173-192.
3. Jones N, Shenk T. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 1978; 13: 181-188.
4. Wohlgemuth JG, Kang SH, Bulboaca GH, Nawotka KA, Calos MP. Long-term gene expression from autonomously replicating vectors in mammalian cells. Gene Therapy 1996; 3: 503-512.
5. Davidson BL et al. Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp Neurol 1994; 125: 258-267.
6. Chartier C et al. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805-4810.
7. He TC et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
8. Mizuguchi H, Kay MA. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998; 9: 2577-2583.
9. Souza DW, Armentano D. Novel cloning method for recombinant adenovirus construction in Escherichia coli. Biotechniques 1999; 26: 502-508.
10. Hardy S et al. Construction of adenovirus vectors through Cre/lox recombination. J Virol 1997; 71: 1842-1849.
11. Aoki K et al. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med 1999; 5: 224-231.
12. Ng P et al. A high-efficiency cre-lox P-based system for construction of adenoviral vectors. Hum Gene Ther 1999; 10: 2667-2672.
13. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
14. Lochmuller H et al. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther 1994; 5: 1485-1491.
15. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
16. Kojima H, Ohishi N, Yagi K. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation. Biochem Biophys Res Commun 1998; 246: 868-872.
17. Ketner G et al. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc Natl Acad Sci USA 1994; 91: 6186-6190.
18. Davis AR, Meyers K, Wilson JM. High throughput method for creating and screening recombinant adenoviruses. Gene Therapy 1998; 5: 1148-1152.
19. Crouzet J et al. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Prof Natl Acad Sci USA 1997; 94: 1414-1419.
20. Fu S, Deisseroth AB. Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors. Hum Gene Ther 1997; 8: 1321-1330.
21. Fallaux FJ et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909-1917.
22. Fallaux FJ et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215-222.
23. Imler JL et al. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Therapy 1996; 3: 75-84.
24. Schiedner G et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 1998; 18: 180-183.
25. Samulski RJ, Chang LS, Shenk T. Helper free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
26. Bartlett JS, Samulski RJ. Genetics and biology of adeno-associated virus. In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press: San Diego, 1995, pp 55-73.